Possible association between HLA antigens and the response to interferon in Japanese patients with chronic hepatitis C

S. Miyaguchi, Hidetsugu Saito, H. Ebinuma, T. Morizane, H. Ishii

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Correlation between the major histocompatibility complex class I antigens (HLA-A, -B and -C) and the elimination from serum of hepatitis C virus in patients with chronic hepatitis C has not been understood. We analyzed HLA phenotypes and their relationship to the efficacy of interferon treatment. Of the 172 patients who were treated with 9 million units of interferon-α2a three times a week for 6 months, 54 patients were responders and 118 patients were non-responders. No significant difference was observed between the 172 patients and 199 healthy subjects with regard to the frequencies of HLA-A, -B and -C antigen phenotypes. However, HLA-B55, B62, CW3 and CW4 frequencies were significantly higher in responders than in non-responders to the interferon treatment, CW4 was found to link with B62, but other phenotypes were independent each other. Patients with HLA B55, B62 and CW3 had a significantly lower viral load, and showed a better response to interferon. These results suggest that HLA system does not have an influence on the evolution towards chronicity of the disease due to hepatitis C virus, but HLA B55, B62 or CW4, and CW3 may be a virus quantity-regulating factors which then affect to response to the interferon treatment, indicating that these HLA antigens in conjunction with a viral peptide is a key target antigen for cytotoxic T lymphocytes in patients with chronic hepatitis C.

Original languageEnglish
Pages (from-to)605-611
Number of pages7
JournalTissue Antigens
Volume49
Issue number6
Publication statusPublished - 1997

Fingerprint

Chronic Hepatitis C
HLA Antigens
Interferons
HLA-A Antigens
HLA-B Antigens
Phenotype
Hepacivirus
Antigens
Histocompatibility Antigens Class I
Cytotoxic T-Lymphocytes
Major Histocompatibility Complex
Viral Load
Healthy Volunteers
Viruses
Peptides
Therapeutics
Serum
HLA-B55 antigen

Keywords

  • Chronic hepatitis C
  • Cytotoxic T cell
  • HLA
  • Interferon
  • Response to treatment

ASJC Scopus subject areas

  • Immunology
  • Cell Biology

Cite this

Possible association between HLA antigens and the response to interferon in Japanese patients with chronic hepatitis C. / Miyaguchi, S.; Saito, Hidetsugu; Ebinuma, H.; Morizane, T.; Ishii, H.

In: Tissue Antigens, Vol. 49, No. 6, 1997, p. 605-611.

Research output: Contribution to journalArticle

@article{1c3846c1989143acadf05f010d1e7d20,
title = "Possible association between HLA antigens and the response to interferon in Japanese patients with chronic hepatitis C",
abstract = "Correlation between the major histocompatibility complex class I antigens (HLA-A, -B and -C) and the elimination from serum of hepatitis C virus in patients with chronic hepatitis C has not been understood. We analyzed HLA phenotypes and their relationship to the efficacy of interferon treatment. Of the 172 patients who were treated with 9 million units of interferon-α2a three times a week for 6 months, 54 patients were responders and 118 patients were non-responders. No significant difference was observed between the 172 patients and 199 healthy subjects with regard to the frequencies of HLA-A, -B and -C antigen phenotypes. However, HLA-B55, B62, CW3 and CW4 frequencies were significantly higher in responders than in non-responders to the interferon treatment, CW4 was found to link with B62, but other phenotypes were independent each other. Patients with HLA B55, B62 and CW3 had a significantly lower viral load, and showed a better response to interferon. These results suggest that HLA system does not have an influence on the evolution towards chronicity of the disease due to hepatitis C virus, but HLA B55, B62 or CW4, and CW3 may be a virus quantity-regulating factors which then affect to response to the interferon treatment, indicating that these HLA antigens in conjunction with a viral peptide is a key target antigen for cytotoxic T lymphocytes in patients with chronic hepatitis C.",
keywords = "Chronic hepatitis C, Cytotoxic T cell, HLA, Interferon, Response to treatment",
author = "S. Miyaguchi and Hidetsugu Saito and H. Ebinuma and T. Morizane and H. Ishii",
year = "1997",
language = "English",
volume = "49",
pages = "605--611",
journal = "HLA",
issn = "2059-2302",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Possible association between HLA antigens and the response to interferon in Japanese patients with chronic hepatitis C

AU - Miyaguchi, S.

AU - Saito, Hidetsugu

AU - Ebinuma, H.

AU - Morizane, T.

AU - Ishii, H.

PY - 1997

Y1 - 1997

N2 - Correlation between the major histocompatibility complex class I antigens (HLA-A, -B and -C) and the elimination from serum of hepatitis C virus in patients with chronic hepatitis C has not been understood. We analyzed HLA phenotypes and their relationship to the efficacy of interferon treatment. Of the 172 patients who were treated with 9 million units of interferon-α2a three times a week for 6 months, 54 patients were responders and 118 patients were non-responders. No significant difference was observed between the 172 patients and 199 healthy subjects with regard to the frequencies of HLA-A, -B and -C antigen phenotypes. However, HLA-B55, B62, CW3 and CW4 frequencies were significantly higher in responders than in non-responders to the interferon treatment, CW4 was found to link with B62, but other phenotypes were independent each other. Patients with HLA B55, B62 and CW3 had a significantly lower viral load, and showed a better response to interferon. These results suggest that HLA system does not have an influence on the evolution towards chronicity of the disease due to hepatitis C virus, but HLA B55, B62 or CW4, and CW3 may be a virus quantity-regulating factors which then affect to response to the interferon treatment, indicating that these HLA antigens in conjunction with a viral peptide is a key target antigen for cytotoxic T lymphocytes in patients with chronic hepatitis C.

AB - Correlation between the major histocompatibility complex class I antigens (HLA-A, -B and -C) and the elimination from serum of hepatitis C virus in patients with chronic hepatitis C has not been understood. We analyzed HLA phenotypes and their relationship to the efficacy of interferon treatment. Of the 172 patients who were treated with 9 million units of interferon-α2a three times a week for 6 months, 54 patients were responders and 118 patients were non-responders. No significant difference was observed between the 172 patients and 199 healthy subjects with regard to the frequencies of HLA-A, -B and -C antigen phenotypes. However, HLA-B55, B62, CW3 and CW4 frequencies were significantly higher in responders than in non-responders to the interferon treatment, CW4 was found to link with B62, but other phenotypes were independent each other. Patients with HLA B55, B62 and CW3 had a significantly lower viral load, and showed a better response to interferon. These results suggest that HLA system does not have an influence on the evolution towards chronicity of the disease due to hepatitis C virus, but HLA B55, B62 or CW4, and CW3 may be a virus quantity-regulating factors which then affect to response to the interferon treatment, indicating that these HLA antigens in conjunction with a viral peptide is a key target antigen for cytotoxic T lymphocytes in patients with chronic hepatitis C.

KW - Chronic hepatitis C

KW - Cytotoxic T cell

KW - HLA

KW - Interferon

KW - Response to treatment

UR - http://www.scopus.com/inward/record.url?scp=0030969984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030969984&partnerID=8YFLogxK

M3 - Article

C2 - 9234482

AN - SCOPUS:0030969984

VL - 49

SP - 605

EP - 611

JO - HLA

JF - HLA

SN - 2059-2302

IS - 6

ER -